Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes

Arthritis and Rheumatism

Volumn 63, Issue 1, 2011, Pages 212-218

  Yuan, Weijia ^a   Dimartino, Stephen J ^a   Redecha, Patricia B ^a   Ivashkiv, Lionel B ^a   Salmon, Jane E ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE COMPLEX DEPOSITION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA EXTRACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ANTIGEN-ANTIBODY COMPLEX; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MONOCYTES; PHOSPHORYLATION; RNA, MESSENGER;

EID: 78650788295     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30083     Document Type: Article

References (24)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A,. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 2001; 19: 683-765.
2. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL,. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152: 3559-69.
3. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM,. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-34.
4. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC,. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4: 393-5.
5. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-7.
6. Mok CC, Lanchbury JS, Chan DW, Lau CS,. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090-5.
7. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4: 421-7. (Pubitemid 24062020)
8. Grondal G, Kristjansdottir H, Gunnlaugsdottir B, Arnason A, Lundberg I, Klareskog L, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999; 42: 1649-54.
9. Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1429-35.
10. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839-44.
11. Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1790-800.
12. Salmon JE, Pricop L,. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease [review]. Arthritis Rheum 2001; 44: 739-50.
13. Berger S, Ballo H, Stutte HJ,. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur J Immunol 1996; 26: 1297-301.
14. Polat GL, Laufer J, Fabian I, Passwell JH,. Cross-linking of monocyte plasma membrane Fcα, Fcγ or mannose receptors induces TNF production. Immunology 1993; 80: 287-92.
15. Debets JM, Van der Linden CJ, Dieteren IE, Leeuwenberg JF, Buurman WA,. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 1988; 141: 1197-201.
16. Anderson CF, Gerber JS, Mosser DM,. Modulating macrophage function with IgG immune complexes. J Endotoxin Res 2002; 8: 477-81.
17. Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, Tarakhovsky A, et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med 2003; 197: 1573-83.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
19. Cairns AP, Crockard AD, Bell AL,. Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 83-6.
20. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5.
21. Aringer M, Smolen JS,. The role of tumor necrosis factor-α in systemic lupus erythematosus. Arthritis Res Ther 2008; 10: 202.
22. Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, et al. Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology (Oxford) 2009; 48: 1451-4.
23. Esposito P, Balletta MM, Procino A, Postiglione L, Memoli B,. Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus 2009; 18: 1329-30.
24. Sharif MN, Tassiulas I, Hu Y, Mecklenbrauker I, Tarakhovsky A, Ivashkiv LB,. IFN-α priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol 2004; 172: 6476-81.